NF-κB-Active Tumors, Matrix CAFs, and Immunosuppression Drive Chemoradiation Resistance in Rectal Cancer
Rectal cancer can survive one of its most aggressive treatment combinations by turning the tissue around the tumor into a ...
Rectal cancer can survive one of its most aggressive treatment combinations by turning the tissue around the tumor into a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine